Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07156357 · ClinicalTrials.gov registry record
Surface EMG Testing on Swallowing in EoE Patients
A clinical trial of Eosinophilic Esophagitis (EoE), sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT07156357 is a study of Eosinophilic Esophagitis (EoE) that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 30 participants, below the 123-participant average among 10 other Eosinophilic Esophagitis (EoE) trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07156357, a study of Eosinophilic Esophagitis (EoE), is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Evaluating swallowing food with surface electromyography (EMG) machine in patients with Eosinophilic Esophagitis
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Surface Electromyography
- DIAGNOSTIC_TEST Fiberoptic Endoscopic Evaluation of Swallowing
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-08-04 |
| Est. Completion | 2027-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07156357
The ClinicalTrials.gov registry entry for NCT07156357 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 123-participant average among 10 other Eosinophilic Esophagitis (EoE) trials with a reported enrollment target (76% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Eosinophilic Esophagitis (EoE) appearing as the primary indexed condition, and to 2 interventions - of which Surface Electromyography is the first listed.
NCT07156357 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT07156357 about?
NCT07156357 is a clinical study titled "Surface EMG Testing on Swallowing in EoE Patients". Evaluating swallowing food with surface electromyography (EMG) machine in patients with Eosinophilic Esophagitis
What is the current status of trial NCT07156357?
This trial is currently recruiting. The enrollment target is 30 participants. The study started on 2025-08-04. Estimated completion is 2027-06.
What conditions does trial NCT07156357 study?
This clinical trial studies the following conditions: Eosinophilic Esophagitis (EoE).
What interventions are being tested in trial NCT07156357?
The interventions under investigation include: Surface Electromyography (DIAGNOSTIC_TEST), Fiberoptic Endoscopic Evaluation of Swallowing (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07156357?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07156357 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Eosinophilic Esophagitis (EoE)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A U.S. Registry of Eosinophilic Esophagitis Pediatric, Adolescent and Adult Patients Treated With DUPIXENT® As Standard of Care
RECRUITING
-
Effect of Dupilumab on the Muscle Function of the Esophagus (food Pipe) in Participants with Eosinophilic Esophagitis (EoE)
RECRUITING · Phase 4
-
A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic Esophagitis
RECRUITING · Phase 3
-
Esophageal String Test Monitoring to Monitor Eosinophilic Esophagitis During Oral Immunotherapy
RECRUITING
-
A Study to Investigate the Efficacy and Safety of NSI-8226 in Adults With Eosinophilic Esophagitis
ACTIVE NOT RECRUITING · Phase 2
-
Study to Investigate the Efficacy and Safety of Dupilumab in Pediatric Patients With Active Eosinophilic Esophagitis (EoE)
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.